Intravenous fluids are fluids which are intended to be administered to a patient intravenously, directly through the circulatory system. These fluids must be sterile to protect patients from injury, and there are a number of different types available for use. The basic function of IV fluids is to replenish the body fluids. Intravenous fluids can also be used as a route of medication administration.
The market for Intravenous (IV) Solution is expected to reach USD 11,511.2 million by 2022 and is expected to grow at a CAGR of 7.69% during the forecast period 2016-2022. The factors which drive the growth of the market are the rising prevalence of chronic diseases, rising acceptance of vitamin C intravenous treatment therapy to treat colorectal cancer. Entrepreneurs who invest in this project will be successful.
Few Indian major players are as under
· Abaris Healthcare Pvt. Ltd.
· Ahlcon Parenterals (India) Ltd.
· Axa Parenterals Ltd.
· Infutec Healthcare Ltd.
· Kokad Pharmaceutical Laboratories Ltd.
· Parenteral Surgicals Ltd.